Abnormal global alternative RNA splicing in COVID-19 patients
Changli Wang,Lijun Chen,Yaobin Chen,Wenwen Jia,Xunhui Cai,Yufeng Liu,Fenghu Ji,Peng Xiong,Anyi Liang,Ren Liu,Yuanlin Guan,Zhongyi Cheng,Yejing Weng,Weixin Wang,Yaqi Duan,Dong Kuang,Sanpeng Xu,Hanghang Cai,Qin Xia,Dehua Yang,Ming-Wei Wang,Xiangping Yang,Jianjun Zhang,Chao Cheng,Liang Liu,Zhongmin Liu,Ren Liang,Guopin Wang,Zhendong Li,Han Xia,Tian Xia
DOI: https://doi.org/10.1371/journal.pgen.1010137
IF: 4.5
2022-04-14
PLoS Genetics
Abstract:Viral infections can alter host transcriptomes by manipulating host splicing machinery. Despite intensive transcriptomic studies on SARS-CoV-2, a systematic analysis of alternative splicing (AS) in severe COVID-19 patients remains largely elusive. Here we integrated proteomic and transcriptomic sequencing data to study AS changes in COVID-19 patients. We discovered that RNA splicing is among the major down-regulated proteomic signatures in COVID-19 patients. The transcriptome analysis showed that SARS-CoV-2 infection induces widespread dysregulation of transcript usage and expression, affecting blood coagulation, neutrophil activation, and cytokine production. Notably, CD74 and LRRFIP1 had increased skipping of an exon in COVID-19 patients that disrupts a functional domain, which correlated with reduced antiviral immunity. Furthermore, the dysregulation of transcripts was strongly correlated with clinical severity of COVID-19, and splice-variants may contribute to unexpected therapeutic activity. In summary, our data highlight that a better understanding of the AS landscape may aid in COVID-19 diagnosis and therapy.
genetics & heredity